| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.079 | 0.2 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.2 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.2 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.2 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |